Technical Analysis for XRTX - Xortx Therapeutics Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| 20 DMA Support | Bullish | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 20 DMA Support | Bullish | -3.88% | |
| Outside Day | Range Expansion | -3.88% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.75% | |
| Stochastic Buy Signal | Bullish | -2.75% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 9 hours ago |
| Rose Above Previous Day's High | about 11 hours ago |
| Rose Above Upper Bollinger Band | about 11 hours ago |
| Fell Below Previous Day's Low | about 11 hours ago |
| 2x Volume Pace | about 11 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-08-14
Xortx Therapeutics Inc Description
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medical Specialties Organ Systems Diabetes Infection Hypertension Kidney Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.35 |
| 52 Week Low | 0.33 |
| Average Volume | 3,458 |
| 200-Day Moving Average | 3.150 |
| 50-Day Moving Average | 2.959 |
| 20-Day Moving Average | 2.477 |
| 10-Day Moving Average | 2.515 |
| Average True Range | 0.225 |
| RSI (14) | 43.82 |
| ADX | 20.02 |
| +DI | 43.198 |
| -DI | 27.021 |
| Chandelier Exit (Long, 3 ATRs) | 3.044 |
| Chandelier Exit (Short, 3 ATRs) | 2.836 |
| Upper Bollinger Bands | 2.736 |
| Lower Bollinger Band | 2.217 |
| Percent B (%b) | 0.51 |
| BandWidth | 20.933 |
| MACD Line | -0.129 |
| MACD Signal Line | -0.175 |
| MACD Histogram | 0.0462 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.020 | ||||
| Resistance 3 (R3) | 3.053 | 2.907 | 2.930 | ||
| Resistance 2 (R2) | 2.907 | 2.769 | 2.890 | 2.900 | |
| Resistance 1 (R1) | 2.693 | 2.684 | 2.620 | 2.660 | 2.870 |
| Pivot Point | 2.547 | 2.547 | 2.510 | 2.530 | 2.547 |
| Support 1 (S1) | 2.333 | 2.409 | 2.260 | 2.300 | 2.090 |
| Support 2 (S2) | 2.187 | 2.324 | 2.170 | 2.060 | |
| Support 3 (S3) | 1.973 | 2.187 | 2.030 | ||
| Support 4 (S4) | 1.940 |
